Home Applications 761154 Application 761154
Type BLA
Sponsor MYLAN PHARMS INC Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761154 Hulio adalimumab-fkjp 351(k) Interchangeable Rx 2026-10-01
Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 HULIO ADALIMUMAB-FKJP INJECTABLE;INJECTION 20MG;0.4ML No No
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 ยท 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Adalimumab ADALIMUMAB-FKJP Biocon Biologics Inc 5cde907d-6747-0e62-db25-1718ee717fe7 2026-01-12 Boxed warning, Warnings, Adverse reactions Exact identifier application number: BLA761154
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.